Banking Law and Nanotechnology Venture Capital in Spain

1. Introduction

“Nanotechnology venture capital” is not a separate legal category under Spanish law. It describes venture-capital investment in companies developing or commercialising nanoscale technologies, such as nanoelectronics, advanced materials, nanomedicine, nanosensors, photonics, semiconductor technologies and nanoscale manufacturing.

The principal Spanish venture-capital statute is Law 22/2014 of 12 November, which regulates venture-capital entities (Entidades de Capital-Riesgo or ECR), other closed-ended collective investment entities and their management companies. The law treats venture capital as an important source of finance from seed and start-up stages through expansion and later corporate development.

Nanotechnology venture capital therefore sits at the intersection of:

banking and financial law;

venture-capital regulation;

company law;

securities law;

intellectual-property law;

EU alternative-investment-fund regulation;

State-aid law;

competition law; and

technology regulation.

The central principle is simple:

The technological nature of the target company does not create a separate financial regime.

A venture fund investing in a Spanish nanotechnology company remains subject to the ordinary venture-capital and financial regulatory framework.

2. Why Venture Capital Matters for Nanotechnology

Nanotechnology businesses can require substantial funding before they generate commercial revenue.

A start-up may need money for:

laboratory research;

prototypes;

patents;

specialist employees;

clean-room facilities;

testing;

regulatory approvals;

manufacturing equipment;

clinical or industrial validation; and

commercial expansion.

Traditional bank debt can be difficult during the earliest stage because a start-up may have:

little revenue;

limited physical collateral;

negative cash flow;

uncertain commercial prospects; and

highly specialized intellectual property.

Venture capital addresses this problem by providing risk capital rather than conventional secured lending.

3. Venture Capital Compared with Bank Lending

The distinction is fundamental.

Traditional Bank Loan

A bank advances money.

The company must repay:

Principal + Interest

The bank normally expects contractual repayment regardless of whether the company's shares increase in value.

Venture Capital

An investor contributes capital and receives an ownership interest.

The investor's return depends largely upon the success and eventual value of the company.

The venture-capital investor therefore accepts substantially more equity risk.

For nanotechnology start-ups, this can make venture capital especially important during the research and commercialization stages.

4. Law 22/2014

Law 22/2014 is the central Spanish legislative framework.

Its stated purpose includes regulation of:

venture-capital entities;

other closed-ended collective investment entities; and

their management companies.

The statute recognizes both venture capital directed towards companies at earlier stages and private-equity investment involving more mature businesses.

An ECR's principal activity generally involves acquiring temporary interests in qualifying companies.

This model is particularly suitable for technology start-ups because the fund can:

acquire shares;

provide strategic support;

assist company growth; and

eventually exit the investment.

5. Closed-Ended Investment

Spanish venture-capital funds normally operate through a closed-ended collective-investment structure.

This differs from an ordinary open-ended retail investment fund.

Investors commit capital to a vehicle, the manager invests the capital in portfolio companies, and investments are normally realized according to the fund's investment and divestment strategy.

Law 22/2014 expressly regulates this closed-ended investment model.

For nanotechnology, a fund might invest in ten different companies developing:

nanosensors;

semiconductor materials;

medical nanoparticles;

advanced batteries;

photonics;

quantum components; and

nano-enabled industrial processes.

This allows investors to spread technology risk across a portfolio.

6. Venture-Capital Companies and Funds

Spanish venture-capital structures can include both corporate and fund vehicles.

A venture-capital company possesses corporate personality.

A venture-capital fund operates as a pool of assets managed through an authorized management structure.

The choice affects matters such as:

governance;

ownership;

investor rights;

management;

documentation; and

distributions.

The underlying objective, however, remains investment in qualifying businesses with the intention of creating value and eventually divesting.

7. Management Companies

Professional management is fundamental to venture capital.

Managers identify investments, conduct due diligence, negotiate transactions and supervise portfolio companies.

For nanotechnology investment, this role becomes particularly demanding because ordinary financial analysis may be insufficient.

The manager may need specialist expertise concerning:

physics;

chemistry;

engineering;

biotechnology;

patents;

semiconductor manufacturing; or

medical regulation.

A venture-capital manager therefore frequently combines financial analysis with external scientific and technical due diligence.

8. CNMV Supervision

The Comisión Nacional del Mercado de Valores (CNMV) is central to Spanish venture-capital regulation.

Law 22/2014 brought venture-capital entities and their managers within a structured system of authorization or registration, supervision, inspection and sanctions.

The framework was also designed to implement the EU Alternative Investment Fund Managers Directive in Spain.

CNMV supervision is important because venture capital involves pooled investor money.

Regulation therefore concerns matters such as:

managers;

registration;

reporting;

investor protection;

conflicts of interest;

valuation;

governance;

marketing; and

regulatory compliance.

The CNMV also maintains an official database of Spanish financial-market jurisprudence.

9. Alternative Investment Fund Managers Directive

Spain's system must also be understood within EU law.

The Alternative Investment Fund Managers Directive, commonly known as AIFMD, regulates managers of alternative investment funds.

Law 22/2014 implemented important elements of this framework in Spain.

The regulatory approach focuses heavily upon the fund manager.

Depending upon the structure and size of the operation, obligations may concern:

authorization;

risk management;

conflicts;

valuation;

transparency;

delegation;

remuneration;

reporting; and

depositary arrangements.

Consequently, a Spanish nanotechnology VC fund cannot be analysed solely through company law.

Financial-regulatory rules apply to the investment-management business itself.

10. ECR-Pyme

Spanish legislation also recognizes ECR-Pyme, a special type of venture-capital entity focused on smaller businesses.

This can be particularly relevant to nanotechnology because many emerging technology businesses begin as SMEs.

The ECR-Pyme regime was introduced to promote venture capital as an alternative source of SME financing, reducing excessive dependence on conventional bank lending. CNMV reporting noted significant growth in these vehicles following the introduction of the regime.

A qualifying nano-start-up may therefore obtain equity capital even where conventional debt financing would be difficult.

11. European Venture Capital Funds

EU Regulation No. 345/2013 established the European Venture Capital Fund (EuVECA) framework.

It facilitates qualifying venture-capital funds operating across the European market.

This is important for nanotechnology because technological businesses often require international capital.

A Spanish nano-start-up might therefore receive investment from:

Spanish VC fund + European VC fund + Corporate investor + Public innovation investor.

This diversification can provide both capital and international expertise.

12. Investment Eligibility

Law 22/2014 defines the basic investment purpose of Spanish ECRs around temporary investments in qualifying businesses. It also establishes investment and diversification requirements.

Nanotechnology itself does not prevent eligibility.

What matters is whether the portfolio company and investment satisfy the applicable statutory requirements.

Thus:

“Nano company” is an industrial description.

“Qualifying venture-capital investment” is a legal classification.

The two questions must be examined separately.

13. Investment Stages

Nanotechnology venture capital can operate at several stages.

Seed Capital

Financing research, patents and initial prototypes.

Start-Up Financing

Funding the creation of the business and first commercial product.

Early-Stage Financing

Supporting testing, certification and early customers.

Growth Financing

Expanding manufacturing capacity and entering new markets.

Later-Stage Financing

Preparing the company for acquisition, substantial private investment or public-market access.

Different stages create different risk levels and valuation problems.

14. Intellectual Property Due Diligence

For many nanotechnology businesses, intellectual property is the principal economic asset.

A VC investor should therefore determine:

who owns the patents;

whether patent applications are pending;

whether university researchers retain rights;

whether licences are exclusive;

whether licences can terminate;

whether employees assigned inventions correctly;

whether competing patents exist; and

whether the technology can lawfully be commercialised.

A company claiming ownership of revolutionary nanoscale technology may have little investment value if another party owns the essential patent.

15. University Spin-Offs

Nanotechnology companies frequently originate from universities or research institutions.

This creates additional legal questions.

Suppose university researchers develop a nanosensor and establish a company.

The venture-capital investor must determine:

University → Technology ownership

Researchers → Inventor rights

Spin-off → Licence/assignment

VC Fund → Equity investment

The investor must ensure that the company possesses sufficiently secure rights to commercialise the technology.

Otherwise, the venture investment may finance a business that does not control its core asset.

16. Valuation

Valuing an early nanotechnology company is difficult.

Traditional valuation methods based upon current profits may provide little assistance because the company may not yet generate revenue.

Investors may instead examine:

patents;

scientific evidence;

prototype development;

addressable market;

regulatory pathway;

manufacturing feasibility;

founding team;

competing technologies;

strategic partnerships; and

probability of commercialization.

Investment can therefore occur through several financing rounds.

For example:

Seed → Series A → Series B → Growth Round → Exit

Each round can establish a new company valuation.

17. Shareholder Agreements

Venture-capital investments usually involve detailed contractual arrangements.

A shareholder agreement may address:

board representation;

voting rights;

information rights;

founder obligations;

transfer restrictions;

anti-dilution mechanisms;

future financing;

intellectual property;

reserved matters; and

exit arrangements.

Spanish company law therefore becomes highly relevant alongside venture-capital regulation.

18. Banks and Venture Capital

Banking law can enter the structure in several ways.

Banks may:

lend to portfolio companies;

provide banking services to VC funds;

participate in investment structures where legally permitted;

provide acquisition financing;

finance later expansion;

manage cash;

provide foreign-exchange services; and

participate in an eventual IPO.

However, equity investment and bank credit remain legally distinct.

A venture investor expects capital appreciation.

A lender primarily expects repayment.

Understanding that distinction is essential when financing high-risk nanotechnology companies.

19. Debt After Venture Capital

VC-backed companies often become more capable of obtaining bank financing after they mature.

For example:

Founders

↓

Seed VC

↓

Series A VC

↓

Commercial Revenue

↓

Bank Debt

Once the company has reliable revenue, assets and established customers, banks may become more willing to provide loans.

Venture capital and banking therefore frequently operate as complementary rather than competing sources of finance.

20. Public Funding and State Aid

Nanotechnology may receive public innovation support because of its potential economic and strategic importance.

Public assistance can include:

grants;

guarantees;

subsidized financing;

co-investment;

research support; and

tax incentives.

However, public support must comply with EU State-aid law.

Article 107 TFEU becomes relevant where State resources provide selective economic advantages capable of affecting competition and trade.

This is particularly important where public money is invested alongside private venture capital.

The public investment cannot simply be assumed lawful because the underlying technology is innovative.

21. Market-Economy Investor Principle

One important State-aid concept is whether a public investor acts under conditions comparable to a rational private-market investor.

For example:

A public investment vehicle and independent VC investors invest simultaneously in a nano-start-up on equivalent economic terms.

This may be materially different from a situation in which the State gives the company unusually favorable capital without commercially rational conditions.

The precise structure therefore matters.

22. Taxation

Tax treatment can significantly affect venture-capital structures.

Relevant questions can include:

taxation of the fund;

taxation of investors;

capital gains;

dividends;

management arrangements;

cross-border investment; and

carried interest or manager remuneration.

Tax advantages must also be examined against applicable EU law where they selectively benefit particular undertakings.

Tax structuring should therefore complement rather than override the financial-regulatory structure.

23. Exit Strategies

Venture capital is generally temporary.

The investor eventually seeks to realise the investment.

Common exits include:

Trade Sale

The nano-start-up is sold to a larger technology company.

Secondary Sale

The VC fund sells its stake to another investor.

IPO

Shares are offered to public-market investors.

Founder/Company Repurchase

Subject to company-law restrictions, shares may be repurchased.

Merger

The portfolio company combines with another business.

The anticipated exit affects the original investment valuation.

24. Insolvency Risk

Nanotechnology venture investment carries substantial failure risk.

A technology may:

fail technically;

fail regulatory approval;

become obsolete;

cost too much to manufacture;

encounter patent disputes; or

fail to obtain customers.

Unlike a secured bank lender, an equity investor normally ranks behind creditors in an insolvency distribution.

Therefore, shareholders may lose their entire investment.

This is part of the economic nature of venture capital.

Relevant Case Laws

There is no established Spanish line of cases specifically called “nanotechnology venture-capital law.” The following authorities are relevant because they establish legal principles applicable to venture investment, financial regulation, public financial incentives, investment structures and State aid.

Case 1 — Banco Santander and Santusa v Commission, Case T-399/11, General Court, 7 November 2014

This litigation concerned Spain's tax treatment of financial goodwill arising from acquisitions of shareholdings in foreign companies.

Principle

The case examined whether a tax advantage connected with corporate share acquisitions constituted selective State aid under Article 107 TFEU.

Relevance to Nanotechnology VC

Venture-capital investment frequently involves acquiring company shares.

Where Spain provides special tax treatment affecting particular investment transactions, EU State-aid rules may become relevant.

A nanotechnology objective does not itself exempt an investment incentive from those rules.

Case 2 — Banco Santander and Santusa v Commission, Case T-399/11 RENV, General Court, 15 November 2018

Following further proceedings, the General Court again examined the Spanish financial-goodwill measure.

Principle

The Court analysed:

the reference tax system;

selective advantage;

differential treatment;

justification; and

legitimate expectations.

Nanotechnology VC Relevance

A preferential tax regime encouraging investment in particular technology companies must be assessed according to its actual structure.

A measure is not outside State-aid law merely because policymakers intend to encourage investment.

Case 3 — Banco Santander and Others v Commission, Joined Cases T-12/15, T-158/15 and T-258/15, General Court, 27 September 2023

This later litigation again concerned Spain's financial-goodwill tax regime.

Principle

The General Court considered questions involving:

unlawful State aid;

recovery;

legal certainty;

legitimate expectations; and

the scope of previous Commission decisions.

Nanotechnology VC Relevance

Suppose investors receive a special tax advantage for acquiring interests in nano-start-ups.

If the measure constitutes unlawful State aid, later recovery can materially alter the economics of the investment.

VC managers must therefore include regulatory risk in investment due diligence.

Case 4 — Commission v World Duty Free Group and Others, Joined Cases C-20/15 P and C-21/15 P, Court of Justice, 21 December 2016

This major EU judgment arose from the same Spanish financial-goodwill regime.

Principle

The Court of Justice clarified the test for selectivity under State-aid law.

A measure can be selective even where access to it is not formally limited to a predefined sector, provided it differentiates between undertakings in comparable situations under the relevant tax system.

Nanotechnology VC Relevance

Spain could not necessarily avoid State-aid scrutiny merely by drafting an innovation-investment incentive in formally general language.

Its practical legal structure must be examined.

Case 5 — World Duty Free Group v Commission, Case C-51/19 P, Court of Justice, 6 October 2021

This later stage of the Spanish State-aid litigation further developed the analysis of tax selectivity.

Principle

Identifying the proper reference system and determining whether a measure creates an unjustified derogation are central to the State-aid assessment.

Nanotechnology VC Relevance

Special tax arrangements for venture investors, technology investors or corporate acquisitions need careful comparison with the ordinary tax system.

The policy objective of encouraging technological development does not by itself settle the State-aid question.

Case 6 — Telefónica Gestión Integral de Edificios y Servicios and Banco Santander v Commission, Joined Cases T-29/14 and T-31/14, General Court, 21 February 2024

These proceedings arose from the Spanish tax-lease system and involved complex investment and tax arrangements.

Principle

Private contractual arrangements cannot eliminate mandatory consequences imposed by EU State-aid law.

Nanotechnology VC Relevance

Assume a nano-infrastructure investment structure contains clauses requiring another party to compensate VC investors if public financial support must later be recovered.

Private agreements cannot themselves prevent public authorities from applying mandatory EU State-aid rules.

The regulatory position must therefore be investigated before investment.

Case 7 — Spanish Supreme Court, Judgment 534/2020, 15 October 2020

This Spanish Supreme Court authority is relevant to determining when an investment arrangement possesses the characteristics of collective investment.

Principle

Important characteristics include:

obtaining money or assets from multiple investors;

collectively investing or managing those resources; and

linking investors' returns to the results of the collective investment.

Nanotechnology VC Relevance

The label given to an investment structure is not necessarily decisive.

If promoters collect capital from multiple investors and collectively invest it in nano-start-ups, financial-regulatory rules may apply according to the arrangement's real legal and economic characteristics.

This prevents promoters from avoiding collective-investment regulation merely by choosing a different contractual label.

25. Practical Example

Assume a Spanish start-up develops nanosensors for industrial equipment.

The company needs €15 million.

A financing structure could operate as follows:

Founders

Invest €500,000 and contribute intellectual property.

Seed Investors

Provide €1.5 million to develop the prototype.

Venture-Capital Fund

Provides €5 million after technical due diligence.

Public Innovation Co-Investment

Provides eligible support under the applicable programme.

Series B Investors

Provide €8 million to commercialise the product.

Before investing, the VC manager examines:

Technology: Does the sensor actually work?

IP: Does the company control the patents?

Corporate: Are founder shares and previous investments valid?

Regulation: Are relevant approvals required?

Market: Will customers buy the technology?

Finance: How long will the capital last?

State aid: Is public support legally compatible?

Exit: Could an industrial company acquire the business later?

This demonstrates that nanotechnology VC requires much more than simply evaluating the scientific idea.

26. Key Risks

Scientific Risk

The underlying research may fail.

Commercialization Risk

A functioning invention may still lack sufficient market demand.

Patent Risk

Another company may own blocking intellectual-property rights.

Founder Risk

Key researchers may leave the business.

Regulatory Risk

Medical, chemical or industrial applications may require approvals.

Financing Risk

The company may require another funding round sooner than expected.

Dilution Risk

Existing investors' percentage ownership can decrease through future capital raising.

Valuation Risk

An early-stage company may be valued above its sustainable economic value.

Exit Risk

The fund may struggle to sell its investment.

State-Aid Risk

Public investment or incentives may face EU legal scrutiny.

27. Governance Protection

VC investors commonly negotiate governance rights because they cannot rely upon contractual loan repayment.

Protection may include:

board seats;

information rights;

approval over major transactions;

restrictions on new share issues;

controls over IP disposal;

founder vesting;

reporting obligations; and

exit provisions.

These rights must operate consistently with Spanish company law and the company's constitutional documents.

28. Why Banking Law Still Matters

At first sight, venture capital appears separate from banking law.

In reality, the two systems interact throughout a company's life cycle.

For example:

VC capital → Research

VC capital → Prototype

VC capital → Commercialization

Bank financing → Working capital

Bank financing → Manufacturing expansion

Investment bank → IPO or corporate sale

A successful nanotechnology company may therefore move gradually from high-risk equity financing toward conventional credit and capital-market financing.

29. Regulatory Structure

The Spanish nanotechnology venture-capital framework can be summarized as:

Law 22/2014

↓

Spanish venture-capital entities and closed-ended investment

↓

CNMV supervision

↓

EU AIFMD framework

↓

Company and securities law

↓

IP and technology regulation

↓

EU State-aid and competition rules

Law 22/2014 remains the core domestic venture-capital legislation, while CNMV materials confirm that it implemented the AIFMD framework for Spanish closed-ended investment management.

30. Core Legal Principles

Spanish nanotechnology venture-capital law can ultimately be understood through several principles.

No Separate Nano-VC Regime

Nanotechnology investment uses the ordinary venture-capital framework.

Venture Capital Is Risk Capital

VC investors generally receive equity rather than a guaranteed repayment claim.

Professional Management Is Regulated

VC managers operate within CNMV and EU regulatory requirements.

Economic Substance Matters

Calling a structure an “innovation club” or “technology partnership” does not necessarily remove collective-investment regulation.

Intellectual Property Is Central

Investment value may depend more upon patents and licences than physical assets.

Public Support Requires State-Aid Analysis

Technology policy does not override EU competition and State-aid requirements.

Investment Is Temporary

Venture capital ordinarily anticipates an eventual exit.

Banking and VC Can Complement Each Other

Equity can finance early development while bank credit becomes increasingly available as the company matures.

Conclusion

Banking law and nanotechnology venture capital in Spain represents the intersection of venture-capital regulation, banking law, company law, securities regulation, intellectual-property law and EU financial law.

Spain does not maintain a special legal category called “nanotechnology venture capital.” Instead, investments in nanoelectronics, nanomaterials, nanosensors, nanomedicine and related technologies operate principally within the framework established by Law 22/2014 and European alternative-investment-fund rules.

The CNMV supervises the regulated venture-capital sector. Venture-capital entities provide an alternative to conventional bank lending by investing risk capital in businesses whose early financial position may make ordinary debt unsuitable. This is particularly significant for nanotechnology companies because they frequently require years of research, patent development and commercialization expenditure before producing stable cash flow.

Bank financing nevertheless remains relevant. As VC-backed businesses mature, they may obtain working-capital facilities, equipment loans, project financing and eventually capital-market services.

The case law is necessarily indirect because there is no developed body of Spanish judgments specifically called “nanotechnology venture-capital cases.” The Spanish Supreme Court's collective-investment jurisprudence helps identify when pooled investment becomes regulated investment activity, while the extensive Banco Santander/World Duty Free line of EU cases demonstrates that tax and public-finance incentives connected with Spanish equity investment remain subject to EU State-aid rules.

The most important practical principle is therefore:

Innovation does not displace financial regulation.

A Spanish venture-capital investment in nanotechnology must satisfy ordinary venture-capital rules while also addressing the special commercial risks created by scientific uncertainty, intellectual-property ownership, regulatory approvals, future funding requirements and technological obsolescence.

Case-Law Qualification

The seven authorities discussed above should not be represented as seven judgments specifically deciding disputes over Spanish nanotechnology venture capital. Such a specialized body of reported jurisprudence does not presently exist. They are broader Spanish/EU venture-investment, collective-investment and State-aid authorities whose principles can apply to the financing structure. This distinction is important for academically accurate legal writing.